Groupama Asset Managment Legend Biotech Corp Transaction History

Groupama Asset Managment

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 14, 2025	BUY	$31.43 - $39.7 $95,547 - $120,688	3,040 Added 6.77%	47,947 $1.68 Billion
Q4 2024 Feb 12, 2025	BUY	$32.49 - $50.28 $569,647 - $881,559	17,533 Added 64.05%	44,907 $1.47 Billion
Q3 2024 Nov 15, 2024	BUY	$43.55 - $59.88 $199,981 - $274,968	4,592 Added 20.16%	27,374 $1.33 Billion
Q2 2024 Aug 14, 2024	BUY	$39.5 - $57.22 $53,720 - $77,819	1,360 Added 6.35%	22,782 $1.01 Billion
Q1 2024 May 14, 2024	BUY	$55.06 - $69.99 $1.18 Million - $1.5 Million	21,422 New	21,422 $1.2 Billion

234

61M

609K

400K

Ticker LEGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 167,403,008
Market Cap $6.19B
Description
Legend Biotech Corporation, a clinical-stage biopharmaceutical company, through its subsidiaries, engages in the discovery and development of novel cell therapies for oncology and other indications in the United States, China, and internationally. Its lead product candidate, LCAR- B38M, is a chimeric antigen receptor for the treatment of multipl...

Get notified when there are updates to the investment portfolio of Groupama Asset Managment, based on Form 13F filings with the SEC.

Stay updated on Groupama Asset Managment with notifications on news.